Should You Buy ECMOHO (MOHO) Stock Today For Its 99% Jump?

Shanghai-based investment solution holding ECMOHO focused on the non-medical health and wellness industry is witnessing its MOHO shares soaring 99% in premarket after it announced 15 days ago an increasingly digital marketing efforts to reach continuous positive marketing outcomes and incomes.

Student Health and Wellness Center | Illinois Institute of Technology

Since January 3 MOHO has tried to surge over $0.50 on average of 470,040 shares. The company strives to cooperate with B2C and B2B firms to win a major market in China alone. Three months ago ECMOHO appointed a new independent director Mr. Yuan to the Board of Directors.

In October 2021 Ms. Zoe Wang, Chairman, and CEO of ECMOHO, said: “As a leading online retail service provider in the field of healthcare and medical equipment in China, ECMOHO has been deeply involved in healthcare, medical equipment, and other health-related industries since its establishment. International and domestic brands such as Puritan’s Pride, Centrum, Caltrate, Harbin Pharmaceuticals, Johnson & Johnson, Sperry, Haier Biomedical, Abbott, Omron, and now Bausch + Lomb, have established in-depth strategic partnerships with ECMOHO, where our Company provides invaluable professional health content services, health key opinion leaders (KOL) and key opinion consumers (KOC) professional matrices, as well as, through continuous exploration, in-depth operation of new media and new traffic, which together helps to empower our partner brands’ business growth in China.”

Seeing this kind of announcements MOHO became a shining opportunity to take maximum profit from its penny shares.